Smoking Cessation

The Healio Editors compiled the most-read news in pulmonology posted in February.

The use of e-cigarettes as a smoking cessation method did not significantly prevent relapse or successful termination, according to survey findings published in Tobacco Control.

Heavy smoking, based on pack-years, in adults with progressive fibrosing interstitial lung disease was associated with increased risk for mortality, according to research published in Respiratory Medicine.

An intervention that utilized smoking-cessation therapy prescribed over the internet was feasible and effective, according to data published in Drug and Alcohol Dependence.

Four different financial incentive programs for smoking cessation were cost-effective from the health care sector perspective, but more expensive from the employer perspective, which may hinder wider adoption, researchers reported.

Among smokers who did not have an initial plan to stop smoking, daily e-cigarette use was associated with higher odds of cigarette discontinuation, according to results published in JAMA Network Open.

Researchers reported that every 5-g increase in daily fiber intake correlated with a nearly 30% lower risk for disease progression or death among patients with melanoma who were treated with immune checkpoint inhibitors.

In young adults, secondhand nicotine vape exposure was associated with an increased risk for bronchitic symptoms and shortness of breath, researchers reported in Thorax.

Quitting smoking at or around time of diagnosis conferred a significant survival benefit for patients with lung cancer, according to results of a meta-analysis published in Journal of Thoracic Oncology.

People with a smoking history who quit, especially at younger ages, avoid much of the excess risk for dying of cancer associated with continued smoking, according to a prospective study published in JAMA Oncology.